Herein, the RNF122 clinical relevance as a prognostic marker, as well as its biological role in glioma, was reported, revealing that the overexpressed RNF122 in human glioma tissue and cell lines improved growth of glioma cells, showing that RNF122 is involved in glioma. Here, RNF122 is linked to central nervous system cancer.